Uterine epithelial cell proliferation and endometrial hyperplasia: Evidence from a mouse model

Molecular Human Reproduction

Volumn 20, Issue 8, 2014, Pages 776-786

  Gao, Yang ^a   Li, Shu ^a   Li, Qinglei ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Endometrial hyperplasia; epithelial cell; Proliferation; Transforming growth factor ; Uterus

Indexed keywords

FIBROBLAST GROWTH FACTOR 10; KI 67 ANTIGEN; MUELLERIAN INHIBITING FACTOR; TRANSFORMING GROWTH FACTOR BETA; ANTI-MULLERIAN HORMONE RECEPTOR; RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENDOMETRIUM CELL; ENDOMETRIUM HYPERPLASIA; EPITHELIUM CELL; FEMALE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; OVARIECTOMY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; ANIMAL; CELL CULTURE; CYTOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; UTERUS;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; ENDOMETRIAL HYPERPLASIA; EPITHELIAL CELLS; FEMALE; MICE; MICE, KNOCKOUT; RECEPTORS, PEPTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UTERUS;

EID: 84904722551     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gau033     Document Type: Article

References (66)

1. Arango NA, Kobayashi A, Wang Y, Jamin SP, Lee HH, Orvis GD, Behringer RR. A mesenchymal perspective of Mullerian duct differentiation and regression in Amhr2-lacZ mice. Mol Reprod Dev 2008; 75:1154-1162.
2. Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science 2002;296:1646-1647.
3. Bazer FW. Uterine adenogenesis and pregnancy: multiple roles for foxa2 in mice. Biol Reprod 2010;83:319-321.
4. Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-b superfamily. Endocr Rev 2002;23:787-823.
5. Chen L, Belton RJ, Nowak RA. Basigin-mediated gene expression changes in mouse uterine stromal cells during implantation. Endocrinology 2009;150:966-976.
6. Daikoku T, Tranguch S, Friedman DB, Das SK, Smith DF, Dey SK. Proteomic analysis identifies immunophilin FK506 binding protein 4 (FKBP52) as a downstream target of Hoxa10 in the periimplantation mouse uterus. Mol Endocrinol 2005;19:683-697.
7. Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008;454:56-61.
8. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. SMAD proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 2010;39:373-384.
9. Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, Wang H. Molecular cues to implantation. Endocr Rev 2004;25:341-373.
10. Diaz FJ, Wigglesworth K, Eppig JJ. Oocytes determine cumulus cell lineage in mouse ovarian follicles. J Cell Sci 2007;120:1330-1340.
11. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996;383:531-535.
12. Dragovic RA, Ritter LJ, Schulz SJ, Amato F, Thompson JG, Armstrong DT, Gilchrist RB. Oocyte-secreted factor activation of SMAD 2/3 signaling enables initiation of mouse cumulus cell expansion. Biol Reprod 2007;76:848-857.
13. Edson MA, Nalam RL, Clementi C, Franco HL, Demayo FJ, Lyons KM, Pangas SA, Matzuk MM. Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development. Mol Endocrinol 2010;24:1251-1266.
14. Filant J, Zhou HJ, Spencer TE. Progesterone inhibits uterine gland development in the neonatal mouse uterus. Biol Reprod 2012;86:1-9.
15. Galloway SM, McNatty KP, Cambridge LM, Laitinen MPE, Juengel JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 2000;25:279-283.
16. Gao Y, Wen H, Wang C, Li Q. SMAD7 antagonizes key TGFb superfamily signaling in mouse granulosa cells in vitro. Reproduction 2013;146:1-11.
17. Gao Y, Bayless KJ, Li Q. TGFBR1 is required for mouse myometrial development. Mol Endocrinol 2014;28:380-394.
18. Gold LI, Parekh TV. Loss of growth regulation by transforming growth factor-beta (TGF-beta) in human cancers: studies on endometrial carcinoma. Semin Reprod Endocr 1999;17:73-92.
19. Gong X, McGee EA. Smad3 is required for normal follicular follicle-stimulating hormone responsiveness in the mouse. Biol Reprod 2009;81:730-738.
20. Hahn HS, Chun YK, Kwon YI, Kim TJ, Lee KH, Shim JU, Mok JE, Lim KT. Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia. Eur J Obstet Gyn R B 2010;150:80-83.
21. Hashimoto O, MooreRK, Shimasaki S. Posttranslational processing of mouse and human BMP-15: potential implication in the determination of ovulation quota. Proc Natl Acad Sci USA 2005;102:5426-5431.
22. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR. Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat Genet 2002;32:408-410.
23. Jeong JW, Kwak I, Lee KY, Kim TH, Large MJ, Stewart CL, Kaestner KH, Lydon JP, DeMayo FJ. Foxa2 is essential for mouse endometrial gland development and fertility. Biol Reprod 2010;83:396-403.
24. Jones RL, Stoikos C, Findlay JK, Salamonsen LA. TGF-beta superfamily expression and actions in the endometrium and placenta. Reproduction 2006;132:217-232.
25. Juengel JL, McNatty KP. The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum Reprod Update 2005;11:144-161.
26. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 1985;56:403-412.
27. Lacey JV, Chia VM. Endometrial hyperplasia and the risk of progression to carcinoma. Maturitas 2009;63:39-44.
28. Larsson J, Goumans MJ, Sjostrand LJ, van Rooijen MA, Ward D, Leveen P, Xu X, ten Dijke P, Mummery CL, Karlsson S. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J 2001;20:1663-1673.
29. Lecanda J, Parekh TV, Gama P, Lin K, Liarski V, Uretsky S, Mittal K, Gold LI. Transforming growth factor-beta, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium. Cancer Res 2007;67:1007-1018.
30. Lee KY, Jeong JW, Wang J, Ma L, Martin JF, Tsai SY, Lydon JP, DeMayo FJ. Bmp2 is critical for the murine uterine decidual response. Mol Cell Biol 2007;27:5468-5478.
31. Li Q, Pangas SA, Jorgez CJ, GraffJM, Weinstein M, Matzuk MM. Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo. Mol Cell Biol 2008;28:7001-7011.
32. Li Q, Agno JE, Edson MA, Nagaraja AK, Nagashima T, Matzuk MM. Transforming growth factor beta receptor type 1 is essential for female reproductive tract integrity and function. PLoS Genet 2011a;7:e1002320.
33. Li Q, Kannan A, DeMayo FJ, Lydon JP, Cooke PS, Yamagishi H, Srivastava D, Bagchi MK, Bagchi IC. The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2. Science 2011b;331:912-916.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
35. Mailleux AA, Kelly R, Veltmaat JM, De Langhe SP, Zalfran S, Thiery JP, Bellusci S. Fgf10 expression identifies parabronchial smooth muscle cell progenitors and is required for their entry into the smooth muscle cell lineage. Development 2005;132:2157-2166.
36. Massague J. The transforming growth-factor-beta family. Annu Rev Cell Biol 1990;6:597-641.
37. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998;67:753-791.
38. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 2000;1:169-178.
39. Massague J. TGFb signalling in context. Nat Rev Mol Cell Biol 2012; 13:616-630.
40. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 1992;360:313-319.
41. Middlebrook BS, Eldin K, Li X, Shivasankaran S, Pangas SA. Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors. Endocrinology 2009;150:5208-5217.
42. Milam MR, Soliman PT, Chung LH, Schmeler KM, Bassett RL, Broaddus RR, Lu KH. Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia. Int J Gynecol Cancer 2008;18:146-151.
43. Mills AM, Longacre TA. Endometrial hyperplasia. Semin Diagn Pathol 2010;27:199-214.
44. Montgomery BE, Daum GS, Dunton CJ. Endometrial hyperplasia: a review. Obstet Gynecol Surv 2004;59:368-378.
45. Nagashima T, Li Q, Clementi C, Lydon JP, Demayo FJ, Matzuk MM. BMPR2 is required for postimplantation uterine function and pregnancy maintenance. J Clin Invest 2013;123:2539-2550.
46. Nomura S, Yoshitomi H, Takano S, Shida T, Kobayashi S, Ohtsuka M, Kimura F, Shimizu H, Yoshidome H, Kato A et al. FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer. Br J Cancer 2008;99:305-313.
47. Pangas SA, Li X, Umans L, Zwijsen A, Huylebroeck D, Gutierrez C, Wang D, Martin JF, Jamin SP, Behringer RR et al. Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice. Mol Cell Biol 2008;28:248-257.
48. Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Cancer Res 2002;62:2778-2790.
49. Petit FG, Jamin SP, Kurihara I, Behringer RR, DeMayo FJ, Tsai M-J, Tsai SY. Deletion of the orphan nuclear receptor COUP-TFII in uterus leads to placental deficiency. Proc Natl Acad Sci USA 2007;104:6293-6298.
50. Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci USA 2010;107:20828-20833.
51. Satterfield MC, Hayashi K, Song G, Black SG, Bazer FW, Spencer TE. Progesterone regulates FGF10, MET, IGFBP1, and IGFBP3 in the endometrium of the ovine uterus. Biol Reprod 2008;79:1226-1236.
52. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003;113:685-700.
53. Shooner C, Caron PL, Frechette-Frigon G, Leblanc V, Dery MC, Asselin E. TGF-beta expression during rat pregnancy and activity on decidual cell survival. Reprod Biol Endocrinol 2005;3:20.
54. Shutter J, WrightTC. Prevalence ofunderlying adenocarcinoma inwomenwith atypical endometrial hyperplasia. Int J Gynecol Pathol 2005;24:313-318.
55. Shynlova OP, Oldenhof AD, Liu MY, Langille L, Lye SJ. Regulation of c-fos expression by static stretch in rat myometrial smooth muscle cells. Am J Obstet Gynecol 2002;186:1358-1365.
56. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
57. Spencer TE, Dunlap KA, Filant J. Comparative developmental biology of the uterus: insights into mechanisms and developmental disruption. Mol Cell Endocrinol 2012;354:34-53.
58. Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WR, Mak TW. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Res 2000;60:3605-3611.
59. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992;359:76-79.
60. Takahashi T, Eitzman B, Bossert NL, Walmer D, Sparrow K, Flanders KC, Mclachlan J, Nelson KG. Transforming growth-factors beta-1, beta-2, and beta-3 messenger-RNA and protein expression in mouse uterus and vagina during estrogen-induced growth-a comparison to other estrogen-regulated genes. Cell Growth Differ 1994;5:919-935.
61. Takase HM, Itoh T, Ino S, Wang T, Koji T, Akira S, Takikawa Y, Miyajima A. FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration. Genes Dev 2013;27:169-181.
62. Tao H, Shimizu M, Kusumoto R, Ono K, Noji S, Ohuchi H. A dual role of FGF10 in proliferation and coordinated migration of epithelial leading edge cells during mouse eyelid development. Development 2005; 132:3217-3230.
63. Thathiah A, Carson DD. Mucins and blastocyst attachment. Rev Endocr Metab Disord 2002;3:87-96.
64. Tomic D, Miller KP, Kenny HA, WoodruffTK, Hoyer P, Flaws JA. Ovarian follicle development requires Smad3. Mol Endocrinol 2004;18:2224-2240.
65. Villacorte M, Suzuki K, Hirasawa A, Ohkawa Y, Suyama M, Maruyama T, Aoki D, Ogino Y, Miyagawa S, Terabayashi T et al. β-Catenin signaling regulates Foxa2 expression during endometrial hyperplasia formation. Oncogene 2013;32:3477-3482.
66. Wood GA, Fata JE, Watson KLM, Khokha R. Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus. Reproduction 2007;133:1035-1044.